{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:14:35Z","timestamp":1790014475195,"version":"4.0.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00216-011-4671-6","type":"journal-article","created":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T05:48:14Z","timestamp":1296452894000},"page":"2843-2853","source":"Crossref","is-referenced-by-count":23,"title":["Inhibitor screening of pharmacological chaperones for lysosomal \u03b2-glucocerebrosidase by capillary electrophoresis"],"prefix":"10.1007","volume":"399","author":[{"given":"Meera","family":"Shanmuganathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Britz-McKibbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,1]]},"reference":[{"key":"4671_CR1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbamcr.2008.08.009","volume":"1793","author":"FM Platt","year":"2009","unstructured":"Platt FM, Lachmann RH (2009) Treating lysosomal storage disorders: Current practice and future prospects. Biochim Biophys Acta Molecul Cell Res 1793:737\u2013745","journal-title":"Biochim Biophys Acta Molecul Cell Res"},{"key":"4671_CR2","first-page":"377","volume":"21","author":"GA Grabowski","year":"1993","unstructured":"Grabowski GA (1993) Gaucher Disease - Enzymology, genetics, and treatment. Adv Hum Genet 21:377\u2013441","journal-title":"Adv Hum Genet"},{"key":"4671_CR3","first-page":"85","volume":"52","author":"E Beutler","year":"1993","unstructured":"Beutler E, Nguyen NJ, Henneberger MW, Smolec JM, McPherson RA, West C, Gelbart T (1993) Gaucher Disease - Gene Frequencies in the Ashkenazi Jewish population Am. J Hum Genet 52:85\u201388","journal-title":"J Hum Genet"},{"key":"4671_CR4","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","volume":"12","author":"AR Sawkar","year":"2005","unstructured":"Sawkar AR, Adamski-Werner SL, Cheng WC, Wong CH, Beutler E, Zimmer KP, Kelly JW (2005) Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles. Chem Biol 12:1235\u20131244","journal-title":"Chem Biol"},{"key":"4671_CR5","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","volume":"273","author":"HH Chang","year":"2006","unstructured":"Chang HH, Asano N, Ishii S, Ichikawa Y, Fan JQ (2006) Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients. FEBS J 273:4082\u20134092","journal-title":"FEBS J"},{"key":"4671_CR6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tips.2004.01.004","volume":"25","author":"AH Futerman","year":"2004","unstructured":"Futerman AH, Sussman JL, Horowitz M, Silman I, Zimran A (2004) New directions in the treatment of Gaucher disease. Trends Pharmacol Sci 25:147\u2013151","journal-title":"Trends Pharmacol Sci"},{"key":"4671_CR7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nchembio0207-84","volume":"3","author":"DA Brooks","year":"2007","unstructured":"Brooks DA (2007) Getting into the fold. Nature Chem Biol 3:84\u201385","journal-title":"Nature Chem. Biol"},{"key":"4671_CR8","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.bbapap.2006.08.012","volume":"1764","author":"T Arakawa","year":"2006","unstructured":"Arakawa T, Ejima D, Kita Y, Tsumoto K (2006) Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs. Biochim Biophys Acta Prot Proteomics 1764:1677\u20131687","journal-title":"Biochim Biophys Acta Prot Proteomics"},{"key":"4671_CR9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tem.2004.05.003","volume":"15","author":"V Bernier","year":"2004","unstructured":"Bernier V, Lagace M, Bichet DG, Bouvier M (2004) Pharmacological chaperones: potential treatment for conformational diseases. Trends Endocrinol Metabol 15:222\u2013228","journal-title":"Trends Endocrinol. Metabol"},{"key":"4671_CR10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0165-6147(03)00158-5","volume":"24","author":"JQ Fan","year":"2003","unstructured":"Fan JQ (2003) A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity. Trends Pharmacol Sci 24:355\u2013360","journal-title":"Trends Pharmacol Sci"},{"key":"4671_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nchembio850","volume":"3","author":"RL Lieberman","year":"2007","unstructured":"Lieberman RL, Wustman BA, Huertas P, Powe AC, Pine CW, Khanna R, Schlossmacher MG, Ringe D, Petsko GA (2007) Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease. Nat Chem Biol 3:101\u2013107","journal-title":"Nat Chem Biol"},{"key":"4671_CR12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.embor.embor873","volume":"4","author":"H Dvir","year":"2003","unstructured":"Dvir H, Harel M, McCarthy AA, Toker L, Silman I, Futerman AH, Sussman JL (2003) X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease. EMBO Rep 4:704\u2013709","journal-title":"EMBO Rep"},{"key":"4671_CR13","doi-asserted-by":"crossref","first-page":"32655","DOI":"10.1074\/jbc.M702387200","volume":"282","author":"CM Walden","year":"2007","unstructured":"Walden CM, Sandhoff R, Chuang CC, Yildiz Y, Butters TD, Dwek RA, Platt FM, van der Spoel AC (2007) Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2 - Implications for spermatogenesis. J Biol Chem 282:32655\u201332664","journal-title":"J Biol Chem"},{"key":"4671_CR14","doi-asserted-by":"crossref","first-page":"13192","DOI":"10.1073\/pnas.0705637104","volume":"104","author":"W Zheng","year":"2007","unstructured":"Zheng W, Padia J, Urban DJ, Jadhav A, Goker-Alpan O, Simeonov A, Goldin E, Auld D, LaMarca ME, Inglese J, Austin CP, Sidransky E (2007) Three classes of gluclocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease. Proc Nat Acad Sci U S A 104:13192\u201313197","journal-title":"Proc Nat Acad Sci U S A"},{"key":"4671_CR15","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/bi9002265","volume":"48","author":"RL Lieberman","year":"2009","unstructured":"Lieberman RL, D\u2019Aquino JA, Ringe D, Petsko GA (2009) Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability. Biochemistry 48:4816\u20134827","journal-title":"Biochemistry"},{"key":"4671_CR16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00018-005-5437-0","volume":"63","author":"AR Sawkar","year":"2006","unstructured":"Sawkar AR, D\u2019Haeze W, Kelly JW (2006) Therapeutic strategies to ameliorate lysosomal storage disorders - a focus on Gaucher disease. Cell Molec Life Sci 63:1179\u20131192","journal-title":"Cell. Molec. Life Sci"},{"key":"4671_CR17","unstructured":"Wang GN, Reinkensmeier G, Zhang SW, Zhou J, Zhang LR, Zhang LH, Butters TD, Ye XS (2009)Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant gaucher disease. J. Med. Chem. 52: 3146\u20133149."},{"key":"4671_CR18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/ac8020455","volume":"81","author":"KR Chalcraft","year":"2009","unstructured":"Chalcraft KR, Britz-McKibbin P (2009) Newborn screening of inborn errors of metabolism by capillary electrophoresis\u2009\u2212\u2009electrospray ionization-mass apectrometry: A second-tier method with improved specificity and sensitivity. Anal Chem 81:307\u2013314","journal-title":"Anal Chem"},{"key":"4671_CR19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1373\/clinchem.2009.141622","volume":"56","author":"D Marsden","year":"2009","unstructured":"Marsden D, Levy H (2009) Newborn screening of lysosomal storage disorders. Clin Chem 56:1071\u20131079","journal-title":"Clin Chem"},{"key":"4671_CR20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1373\/clinchem.2005.048553","volume":"51","author":"DS Millington","year":"2005","unstructured":"Millington DS (2005) Newborn screening for lysosomal storage disorders. Clin Chem 51:808\u2013809","journal-title":"Clin Chem"},{"key":"4671_CR21","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.0604348103","volume":"103","author":"J Inglese","year":"2006","unstructured":"Inglese J, Auld DS, Jadhav A, Johnson RL, Simeonov A, Yasgar A, Zheng W, Austin CP (2006) Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc Nat Acad Sci U S A 103:11473\u201311478","journal-title":"Proc Nat Acad Sci U S A"},{"key":"4671_CR22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bbrc.2008.02.125","volume":"369","author":"JS Shen","year":"2008","unstructured":"Shen JS, Edwards NJ, Bin Hong Y, Murray GJ (2008) Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase. Biochem Biophys Res Commun 369:1071\u20131075","journal-title":"Biochem Biophys Res Commun"},{"key":"4671_CR23","unstructured":"Sawkar AR, Cheng WC, Beutler E, Wong CH, Balch WE, Kelly JW (2002)Chemical chaperones increase the cellular activity of N370S beta-glucosidase: A therapeutic strategy for Gaucher disease. Proc. Nat. Acad. Sci. U.S.A. 99: 15428\u201315433."},{"key":"4671_CR24","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","volume":"284","author":"GHB Maegawa","year":"2009","unstructured":"Maegawa GHB, Tropak MB, Buttner JD, Rigat BA, Fuller M, Pandit D, Tang LI, Kornhaber GJ, Hamuro Y, Clarke JTR, Mahuran DJ (2009) Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease. J Biol Chem 284:23502\u201323516","journal-title":"J Biol Chem"},{"key":"4671_CR25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrd1086","volume":"2","author":"KH Bleicher","year":"2003","unstructured":"Bleicher KH, Bohm HJ, Muller K, Alanine AI (2003) Hit and lead generation: Beyond high-throughput screening. Nat Rev Drug Disc 2:369\u2013378","journal-title":"Nat Rev Drug Disc"},{"key":"4671_CR26","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1002\/elps.200700942","volume":"29","author":"J Zhang","year":"2008","unstructured":"Zhang J, Hoogmartens J, Van Schepdael A (2008) Kinetic study of cytochrome P450 by capillary electrophoretically mediated microanalysis. Electrophoresis 29:3694\u20133700","journal-title":"Electrophoresis"},{"key":"4671_CR27","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/elps.201000187","volume":"31","author":"JMA Gavina","year":"2010","unstructured":"Gavina JMA, White CE, Finan TM, Britz-McKibbin P (2010) Determination of 4-hydroxyproline-2-epimerase activity by capillary electrophoresis: A stereoselective platform for inhibitor screening of amino acid isomerases. Electrophoresis 31:2831\u20132837","journal-title":"Electrophoresis"},{"key":"4671_CR28","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1002\/elps.200600133","volume":"27","author":"D Koval","year":"2006","unstructured":"Koval D, Kasicka V, Jiracek J, Collinsova M (2006) Determination of pKa values of diastereomers of phosphinic pseudopeptides by CZE. Electrophoresis 27:4648\u20134657","journal-title":"Electrophoresis"},{"key":"4671_CR29","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1021\/ac000145o","volume":"72","author":"LJ Ma","year":"2000","unstructured":"Ma LJ, Gong XY, Yeung ES (2000) Combinatorial screening of enzyme activity by using multiplexed capillary electrophoresis. Anal Chem 72:3383\u20133387","journal-title":"Anal Chem"},{"key":"4671_CR30","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S1359-6446(04)03293-3","volume":"9","author":"HM Pang","year":"2004","unstructured":"Pang HM, Kenseth J, Coldiron S (2004) High-throughput multiplexed capillary electrophoresis in drug discovery. Drug Discov Today 9:1072\u20131080","journal-title":"Drug Discov Today"},{"key":"4671_CR31","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1021\/ac8020938","volume":"81","author":"S Jambovane","year":"2009","unstructured":"Jambovane S, Duin EC, Kirn SK, Hong JW (2009) Determination of kinetic parameters, Km and kcat with a single experiment on a chip. Anal Chem 81:3239\u20133245","journal-title":"Anal Chem"},{"key":"4671_CR32","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jpba.2010.04.005","volume":"53","author":"Y Fan","year":"2010","unstructured":"Fan Y, Scriba GKE (2010) Advances in-capillary electrophoretic enzyme assays. J Pharma Biomed Anal 53:1076\u20131090","journal-title":"J. Pharma. Biomed. Anal"},{"key":"4671_CR33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/elps.200500492","volume":"27","author":"J Zhang","year":"2006","unstructured":"Zhang J, Hoogmartens J, Van Schepdael A (2006) Advances in capillary electrophoretically mediated microanalysis: An update. Electrophoresis 27:35\u201343","journal-title":"Electrophoresis"},{"key":"4671_CR34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/elps.200900373","volume":"31","author":"J Zhang","year":"2009","unstructured":"Zhang J, Hoogmartens J, Van Schepdael A (2009) Recent developments and applications of EMMA in enzymatic and derivatization reactions. Electrophoresis 31:65\u201373","journal-title":"Electrophoresis"},{"key":"4671_CR35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/elps.200305741","volume":"25","author":"M Telnarova","year":"2004","unstructured":"Telnarova M, Vytiskova S, Chaloupkova R, Glatz Z (2004) Study of enzymatic reaction by electrophoretically mediated microanalysis in a partially filled capillary with indirect or direct detection. Electrophoresis 25:290\u2013296","journal-title":"Electrophoresis"},{"key":"4671_CR36","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1002\/elps.200800013","volume":"29","author":"J Iqbal","year":"2008","unstructured":"Iqbal J, Levesque SA, Sevigny J, Muller CE (2008) A highly sensitive CE-UV method with dynamic coating of silica-fused capillaries for monitoring of nucleotide pyrophosphatase\/phosphodiesterase reactions. Electrophoresis 29:3685\u20133693","journal-title":"Electrophoresis"},{"key":"4671_CR37","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/elps.200390130","volume":"24","author":"Y Kanie","year":"2003","unstructured":"Kanie Y, Kanie O (2003) Electrophoretically mediated reaction of glycosidases at a nanoliter scale. Electrophoresis 24:1111\u20131118","journal-title":"Electrophoresis"},{"key":"4671_CR38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ab.2007.09.028","volume":"373","author":"J Iqbal","year":"2008","unstructured":"Iqbal J, Jirovsky D, Lee SY, Zimmermann H, Muller CE (2008) Capillary electrophoresis-based nanoscale assays for monitoring ecto-5\u2032-nucleotidase activity and inhibition in preparations of recombinant enzyme and melanoma cell membranes. Anal Biochem 373:129\u2013140","journal-title":"Anal Biochem"},{"key":"4671_CR39","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/1522-2683(200209)23:17<2854::AID-ELPS2854>3.0.CO;2-Y","volume":"23","author":"S Dyck Van","year":"2002","unstructured":"Van Dyck S, Van Schepdael A, Hoogmartens J (2002) Kinetic study of \u03b3-glutamyltransferase activity by electrophoretically mediated microanalysis combined with micellar electrokinetic capillary chromatography. Electrophoresis 23:2854\u20132859","journal-title":"Electrophoresis"},{"key":"4671_CR40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/elps.200600327","volume":"28","author":"ZM Tang","year":"2007","unstructured":"Tang ZM, Wang ZY, Kang JW (2007) Screening of acetylcholinesterase inhibitors in natural extracts by CE with electrophoretically mediated microanalysis technique. Electrophoresis 28:360\u2013365","journal-title":"Electrophoresis"},{"key":"4671_CR41","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/jssc.200800701","volume":"32","author":"Y Martin-Biosca","year":"2009","unstructured":"Martin-Biosca Y, Asensi-Bernardi L, Villanueva-Camanas RM, Sagrado S, Medina-Hernandez MJ (2009) Screening of acetylcholinesterase inhibitors by CE after enzymatic reaction at capillary inlet. J Sep Sci 32:1748\u20131756","journal-title":"J Sep Sci"},{"key":"4671_CR42","first-page":"343","volume":"D59","author":"D Roeber","year":"2003","unstructured":"Roeber D, Achari A, Manavalan P, Edmunds T, Scott DL (2003) Cystallization and repliminary X-ray analysis of recombinant human acid beta-glucocerebrosidase, a treatment for Gaucher\u2019s disease. Acta Crystallogr D59:343\u2013344","journal-title":"Acta Crystallogr"},{"key":"4671_CR43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/glycob\/cwp138","volume":"20","author":"B Brumshtein","year":"2010","unstructured":"Brumshtein B, Salinas P, Peterson B, Chan V, Silman I, Sussman JL, Savickas PJ, Robinson GS, Futerman AH (2010) Characterization of gene-activated human acid-beta-glucosidase: Crystal structure, glycan composition, and internalization into macrophages. Glycobiology 20:24\u201332","journal-title":"Glycobiology"},{"key":"4671_CR44","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3109\/14756360902829766","volume":"24","author":"M Yoshino","year":"2009","unstructured":"Yoshino M, Murakami K (2009) A graphical method for determining inhibition constants. J Enzyme Inhibition Med Chem 24:1288\u20131290","journal-title":"J. Enzyme Inhibition Med. Chem"},{"key":"4671_CR45","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0090-9556(24)15316-0","volume":"27","author":"T Kakkar","year":"1999","unstructured":"Kakkar T, Boxenbaum H, Mayersohn M (1999) Estimation of Ki in a competitive enzyme-inhibition model: Comparisons among three methods of data analysis. Drug Metab Dispos 27:756\u2013762","journal-title":"Drug Metab Dispos"},{"key":"4671_CR46","doi-asserted-by":"crossref","unstructured":"Maurer T, Fung H-L (2000) Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: Application to nitric oxide synthase. AAPS PharmSci. 2: article 8.","DOI":"10.1208\/ps020108"},{"key":"4671_CR47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nprot.2009.182","volume":"5","author":"G Kemmer","year":"2010","unstructured":"Kemmer G, Keller S (2010) Nonlinear least-squares data fitting in Excel spreadsheets. Nat Protocol 5:267\u2013281","journal-title":"Nat Protocol"},{"key":"4671_CR48","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1042\/bj3110981","volume":"311","author":"WW-C Chan","year":"1995","unstructured":"Chan WW-C (1995) Combination plots as graphical tools in the study of enzyme inhibition. Biochem J 311:981\u2013985","journal-title":"Biochem J"},{"key":"4671_CR49","unstructured":"Geng W, Ke J, Satoh H, Bush ED (2001) A numerical method for identification of inhibition mechanism and estimation of inhibition constant Ki0 in in-vitro enzyme inhibition study I : A computer simulation study AAPS PharmaSci 3: W4464."},{"key":"4671_CR50","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1517\/13543784.2010.524205","volume":"19","author":"BE Smid","year":"2010","unstructured":"Smid BE, Aerts JMFG, Boot RG, Linthorst FE, Hollak CEM (2010) Pharmacological small molecules for the treatment of lysosomal storage disorders. Expert Opin Investig Drugs 19:1367\u20131379","journal-title":"Expert Opin Investig Drugs"},{"key":"4671_CR51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/138620708786734244","volume":"11","author":"DJ Urban","year":"2008","unstructured":"Urban DJ, Zheng W, Goker-Alpan O, Jadhav A, LaMarca ME, Inglese J, Sidransky E, Austin CP (2008) Optimization and validation of two miniaturized glucocerebrosidase enzyme assays for high throughput screening. Combinat Chem High Throughput Screen 11:817\u2013824","journal-title":"Combinat Chem High Throughput Screen"},{"key":"4671_CR52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0003-9861(76)90547-6","volume":"175","author":"SP Peters","year":"1976","unstructured":"Peters SP, Coyle P, Glew RH (1976) Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate. Arch Biochem Biophys 175:569\u2013582","journal-title":"Arch Biochem Biophys"},{"key":"4671_CR53","doi-asserted-by":"crossref","unstructured":"Kaiser C, Segui-Lines G, D\u2019Amaral JC, Ptolemy AS, Britz-McKibbin P (2008) Electrokinetic probes for single-step screening of polyol stereoisomers: the virtues of ternary boronate ester complex formation. Chem. Comm. 338\u2013340.","DOI":"10.1039\/B714215C"},{"key":"4671_CR54","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.1021\/ja001762x","volume":"122","author":"A Bulow","year":"2000","unstructured":"Bulow A, Plesner IW, Bols M (2000) A large difference in the thermodynamics of binding of isofagomine and 1-deoxynojirimycin to beta-glucosidase. J Am Chem Soc 122:8567\u20138568","journal-title":"J Am Chem Soc"},{"key":"4671_CR55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ymgme.2008.12.008","volume":"96","author":"B Rigat","year":"2009","unstructured":"Rigat B, Mahuran D (2009) Diltiazem, a L-type calcium channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells. Molec Genet Metab 96:225\u2013232","journal-title":"Molec Genet Metab"},{"key":"4671_CR56","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1517\/17425255.4.8.1119","volume":"4","author":"M Malerba","year":"2008","unstructured":"Malerba M, Ragnoli B (2008) Ambroxol in the 21st century: Pharmacological and clinical update. Expert Opin Drug Metab Toxicol 4:1119\u20131129","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4671_CR57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/mutage\/16.1.31","volume":"16","author":"K Gasiorowski","year":"2001","unstructured":"Gasiorowski K, Brokos B, Szyba K, Leszek J (2001) Antimutagenic activity of fluphenazine in short-term tests. Mutagenesis 16:31\u201338","journal-title":"Mutagenesis"},{"key":"4671_CR58","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1432-1033.1990.tb19173.x","volume":"191","author":"SV Weely","year":"1990","unstructured":"Weely SV, Aerts JMFG, Leeuwen MBV, Heikoop JC, Donker-Koopman WE, Barranger JA, Tager JM, Schram AW (1990) Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase. Eur J Biochem 191:669\u2013677","journal-title":"Eur J Biochem"},{"key":"4671_CR59","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","volume":"103","author":"RA Steet","year":"2006","unstructured":"Steet RA, Chung S, Wustman B, Powe A, Do H, Kornfeld SA (2006) The iminosugar isofagomine increases the activity of N370S mutant acid \u03b2-glucosidase in Gaucher fibroblasts by several mechanisms. Proc Nat Acad Sci U S A 103:13813\u201313818","journal-title":"Proc Nat Acad Sci U S A"},{"key":"4671_CR60","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/cbic.200800249","volume":"9","author":"GJ Kornhaber","year":"2008","unstructured":"Kornhaber GJ, Tropak BB, Maegawa GH, Tuske SJ, Coales SJ, Mahuran DJ, Hamuro Y (2008) Isofagomine induced stabilization of glucocerebrosidase. Chembiochem 9:2643\u20132649","journal-title":"Chembiochem"},{"key":"4671_CR61","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1742-4658.2010.07588.x","volume":"277","author":"R Khanna","year":"2010","unstructured":"Khanna R, Benjamin ER, Pellegrino L, Schilling A, Rigat BA, Soska R, Nafar H, Ranes BE, Feng J, Lun Y, Powe AC, Palling DJ, Wustman BA, Schiffmann R, Mahuran DJ, Lockhart DJ, Valenzano KJ (2010) The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase. FEBS J 277:1618\u20131638","journal-title":"FEBS J"},{"key":"4671_CR62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/bi802121g","volume":"48","author":"JMA Gavina","year":"2009","unstructured":"Gavina JMA, Mazhab-Jafari MT, Melacini G, Britz-McKibbin P (2009) Label-Free assay for thermodynamic analysis of protein-ligand interactions: A multivariate strategy for allosteric ligand screening. Biochemistry 48:223\u2013225","journal-title":"Biochemistry"},{"key":"4671_CR63","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrd746","volume":"1","author":"A Christopoulos","year":"2002","unstructured":"Christopoulos A (2002) Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discovery 1:198\u2013210","journal-title":"Nat Rev Drug Discovery"},{"key":"4671_CR64","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1002\/cbic.200800304","volume":"9","author":"MB Tropak","year":"2008","unstructured":"Tropak MB, Kornhaber GJ, Rigat BA, Maegawa GH, Buttner JD, Blanchard JE, Murphy C, Tuske SJ, Coales SJ, Hamuro Y, Brown ED, Mahuran DJ (2008) Identification of pharmacological chaperones for Gaucher disease and characterization of their effects on beta-glucocerebrosidase by hydrogen\/deuterium exchange mass spectrometry. Chembiochem 9:2650\u20132662","journal-title":"Chembiochem"},{"key":"4671_CR65","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1074\/jbc.M609304200","volume":"282","author":"GH Maegawa","year":"2007","unstructured":"Maegawa GH, Tropak M, Buttner J, Stockley T, Kok F, Clarke JT, Mahuran DJ (2007) Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis. J Biol Chem 282:9150\u20139161","journal-title":"J Biol Chem"},{"key":"4671_CR66","doi-asserted-by":"crossref","first-page":"15495","DOI":"10.1021\/jp904805t","volume":"113","author":"K Cieslik-Boczula","year":"2009","unstructured":"Cieslik-Boczula K, Szwed J, Jaszczyszyn A, Gasiorowski K, Koll A (2009) Interactions of dihydrochloride fluphenazine with DPPC liposomes: ATR-IR and 31P NMR Studies. J Phys Chem B 113:15495\u201315502","journal-title":"J Phys Chem B"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-011-4671-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-011-4671-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-011-4671-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T07:42:20Z","timestamp":1740901340000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-011-4671-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,1]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["4671"],"URL":"https:\/\/doi.org\/10.1007\/s00216-011-4671-6","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,1]]}}}